Download PDF
Digestive Disease Interventions 2022; 06(02): 075-085
DOI: 10.1055/s-0042-1748021
Review Article

Portal Hypertension: Current Surgical Management

Lauren M. Wancata
1   Depatment of Surgery, Virginia Mason Franciscan Health, Seattle, Washington
,
Christopher R. Connelly
2   Department of Surgery, Oregon Health and Science University, Portland, Oregon
,
Susan L. Orloff
2   Department of Surgery, Oregon Health and Science University, Portland, Oregon
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Portal hypertension occurs due to multiple disorders of the liver and its circulation. It is defined as an elevated pressure gradient between the portal circulation and the systemic circulation. The primary clinical consequences of portal hypertension are ascites and the development of portosystemic varices, which may cause life threatening hemorrhage. Modern management of portal hypertension includes medical, endoscopic therapy and transjugular intrahepatic portosystemic shunt placement by interventional radiology. Historically, portal hypertension was treated through the creation of surgical portosystemic shunts. In this chapter, the physiology of portal hypertension and the approaches to its management will be discussed. Specifically, the chapter will focus on indications, technical considerations, and types of surgical shunts used to treat portal hypertension, as well as literature supporting these procedures. Three case reports describing recent successful surgical shunt creation will be presented. Although portosystemic surgical shunt creation is performed far less frequently as medical, endoscopic and radiologic interventions have improved, this chapter illustrates that this procedure is a vital tool to be used in the treatment of portal hypertension.

Keywords

portal hypertension - transjugular intrahepatic portosystemic shunt - surgical portosystemic shunts - outcomes


Publication History

Received: 06 December 2021

Accepted: 24 January 2022

Article published online:
13 June 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Simonetto DA, Liu M, Kamath PS. Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clin Proc 2019; 94 (04) 714-726
    CrossrefPubMedSearch in Google Scholar
  • 2 Turco L, Garcia-Tsao G. Portal Hypertension: Pathogenesis and Diagnosis. Clin Liver Dis 2019; 23 (04) 573-587
    CrossrefPubMedSearch in Google Scholar
  • 3 Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 2013; 7 (02) 141-155
    CrossrefPubMedSearch in Google Scholar
  • 4 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Practice Guidelines Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46 (03) 922-938
    CrossrefPubMedSearch in Google Scholar
  • 5 Zhao JR, Wang GC, Hu JH, Zhang CQ. Risk factors for early rebleeding and mortality in acute variceal hemorrhage. World J Gastroenterol 2014; 20 (47) 17941-17948
    CrossrefPubMedSearch in Google Scholar
  • 6 ter Borg PC, Hollemans M, Van Buuren HR. et al. Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years. Radiology 2004; 231 (02) 537-545
    CrossrefPubMedSearch in Google Scholar
  • 7 Orloff MJ, Duguay LR, Kosta LD. Criteria for selection of patients for emergency portacaval shunt. Am J Surg 1977; 134 (01) 146-152
    CrossrefPubMedSearch in Google Scholar
  • 8 Mikkelsen WP. Therapeutic portacaval shunt. Preliminary data on controlled trial and morbid effects of acute hyaline necrosis. Arch Surg 1974; 108 (03) 302-305
    CrossrefPubMedSearch in Google Scholar
  • 9 Sauerbruch T, Wong F. Treatment of Oesophageal Varices in Liver Cirrhosis. Digestion 2019; 99 (04) 261-266
    CrossrefPubMedSearch in Google Scholar
  • 10 Zanetto A, Garcia-Tsao G. Management of acute variceal hemorrhage. F1000 Res 2019; 8 :F1000 Faculty Rev-966
    CrossrefPubMedSearch in Google Scholar
  • 11 Zhou Y, Zhang W, Zhang Z. et al. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks. Eur J Gastroenterol Hepatol 2020; 32 (09) 1235-1243
    CrossrefPubMedSearch in Google Scholar
  • 12 Eck.
    PubMed
  • 13 Whipple AO. The Problem of Portal Hypertension in Relation to the Hepatosplenopathies. Ann Surg 1945; 122 (04) 449-475
    CrossrefPubMedSearch in Google Scholar
  • 14 Henderson JM, Anderson CD. The Surgical Treatment of Portal Hypertension. Clin Liver Dis (Hoboken) 2020; 15 (Suppl. 01) S52-S63
    CrossrefPubMedSearch in Google Scholar
  • 15 Mercado MA. Surgical treatment for portal hypertension. Br J Surg 2015; 102 (07) 717-718
    CrossrefPubMedSearch in Google Scholar
  • 16 Orloff MJ. Fifty-three years' experience with randomized clinical trials of emergency portacaval shunt for bleeding esophageal varices in Cirrhosis: 1958-2011. JAMA Surg 2014; 149 (02) 155-169
    CrossrefPubMedSearch in Google Scholar
  • 17 Henderson JM, Boyer TD, Kutner MH. et al; DIVERT Study Group. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 2006; 130 (06) 1643-1651
    CrossrefPubMedSearch in Google Scholar
  • 18 Resnick RH, Chalmers TC, Ishihara AM. et al. A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med 1969; 70 (04) 675-688
    CrossrefPubMedSearch in Google Scholar
  • 19 Orloff MJ, Charters III AC, Chandler JG. et al. Portacaval shunt as emergency procedure in unselected patients with alcoholic cirrhosis. Surg Gynecol Obstet 1975; 141 (01) 59-68
    PubMedSearch in Google Scholar
  • 20 Kirby R, Burke FD, Jones JD. Emergency and elective surgical treatment of portal hypertension. A review of 23 years' experience. Ann R Coll Surg Engl 1975; 57 (03) 148-158
    PubMedSearch in Google Scholar
  • 21 Orloff MJ, Bell Jr RH, Hyde PV, Skivolocki WP. Long-term results of emergency portacaval shunt for bleeding esophageal varices in unselected patients with alcoholic cirrhosis. Ann Surg 1980; 192 (03) 325-340
    CrossrefPubMedSearch in Google Scholar
  • 22 Cameron JL, Maddrey WC. Mesoatrial shunt: a new treatment for the Budd-Chiari syndrome. Ann Surg 1978; 187 (04) 402-406
    CrossrefPubMedSearch in Google Scholar
  • 23 Millikan Jr WJ, Henderson JM, Sewell CW. et al. Approach to the spectrum of Budd-Chiari syndrome: which patients require portal decompression?. Am J Surg 1985; 149 (01) 167-176
    CrossrefPubMedSearch in Google Scholar
  • 24 Chezmar JL, Bernardino ME. Mesoatrial shunt for the treatment of Budd-Chiari syndrome: radiologic evaluation in eight patients. AJR Am J Roentgenol 1987; 149 (04) 707-710
    CrossrefPubMedSearch in Google Scholar
  • 25 Slakey DP, Klein AS, Venbrux AC, Cameron JL. Budd-Chiari syndrome: current management options. Ann Surg 2001; 233 (04) 522-527
    CrossrefPubMedSearch in Google Scholar
  • 26 Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg 1986; 204 (04) 356-363
    CrossrefPubMedSearch in Google Scholar
  • 27 Collins JC, Ong MJ, Rypins EB, Sarfeh IJ. Partial portacaval shunt for variceal hemorrhage: longitudinal analysis of effectiveness. Arch Surg 1998; 133 (06) 590-592 , discussion 592–594
    CrossrefPubMedSearch in Google Scholar
  • 28 Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial. Ann Surg 1994; 219 (04) 353-361
    CrossrefPubMedSearch in Google Scholar
  • 29 Warren WD, Zeppa R, Fomon JJ. Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967; 166 (03) 437-455
    CrossrefPubMedSearch in Google Scholar
  • 30 Warren WD, Millikan Jr WJ, Henderson JM. et al. Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg 1982; 195 (05) 530-542
    CrossrefPubMedSearch in Google Scholar
  • 31 Potts III JR, Henderson JM, Millikan Jr WJ, Warren WD. Emergency distal splenorenal shunts for variceal hemorrhage refractory to nonoperative control. Am J Surg 1984; 148 (06) 813-816
    CrossrefPubMedSearch in Google Scholar
  • 32 Millikan Jr WJ, Warren WD, Henderson JM. et al. The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten year follow-up. Ann Surg 1985; 201 (06) 712-722
    CrossrefPubMedSearch in Google Scholar
  • 33 Langer B, Taylor BR, Mackenzie DR, Gilas T, Stone RM, Blendis L. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life. Gastroenterology 1985; 88 (02) 424-429
    CrossrefPubMedSearch in Google Scholar
  • 34 Warren WD, Henderson JM, Millikan WJ, Galambos JT, Bryan FC. Management of variceal bleeding in patients with noncirrhotic portal vein thrombosis. Ann Surg 1988; 207 (05) 623-634
    CrossrefPubMedSearch in Google Scholar
  • 35 Henderson JM, Kutner MH, Millikan Jr WJ. et al. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Ann Intern Med 1990; 112 (04) 262-269
    CrossrefPubMedSearch in Google Scholar
  • 36 Jin GL, Rikkers LF. Selective variceal decompression: current status. HPB Surg 1991; 5 (01) 1-15
    CrossrefPubMedSearch in Google Scholar
  • 37 Rikkers LF, Jin G, Burnett DA, Buchi KN, Cormier RA. Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial. Am J Surg 1993; 165 (01) 27-32 , discussion 32–33
    CrossrefPubMedSearch in Google Scholar
  • 38 Orozco H, Mercado MA, Granados Garcia J. et al. Selective shunts for portal hypertension: current role of a 21-year experience. Liver Transpl Surg 1997; 3 (05) 475-480
    CrossrefPubMedSearch in Google Scholar
  • 39 Orloff MJ, Isenberg JI, Wheeler HO. et al. Randomized trial of emergency endoscopic sclerotherapy versus emergency portacaval shunt for acutely bleeding esophageal varices in cirrhosis. J Am Coll Surg 2009; 209 (01) 25-40
    CrossrefPubMedSearch in Google Scholar
  • 40 Orloff MJ, Vaida F, Haynes KS, Hye RJ, Isenberg JI, Jinich-Brook H. Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis. J Gastrointest Surg 2012; 16 (11) 2094-2111
    CrossrefPubMedSearch in Google Scholar
  • 41 Orloff MJ, Hye RJ, Wheeler HO. et al. Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis. Surgery 2015; 157 (06) 1028-1045
    CrossrefPubMedSearch in Google Scholar
  • 42 Rosemurgy AS, Goode SE, Zwiebel BR, Black TJ, Brady PG. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg 1996; 224 (03) 378-384 , discussion 384–386
    CrossrefPubMedSearch in Google Scholar
  • 43 Rosemurgy AS, Frohman HA, Teta AF, Luberice K, Ross SB. Prosthetic H-graft portacaval shunts vs transjugular intrahepatic portasystemic stent shunts: 18-year follow-up of a randomized trial. J Am Coll Surg 2012; 214 (04) 445-453 , discussion 453–455
    CrossrefPubMedSearch in Google Scholar
  • 44 Rosemurgy AS, Serafini FM, Zweibel BR. et al. Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg 2000; 4 (06) 589-597
    CrossrefPubMedSearch in Google Scholar
  • 45 Ockenga J, Kroencke TJ, Schuetz T. et al. Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents. Scand J Gastroenterol 2004; 39 (10) 994-999
    CrossrefPubMedSearch in Google Scholar
  • 46 Maleux G, Nevens F, Wilmer A. et al. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures. Eur Radiol 2004; 14 (10) 1842-1850
    CrossrefPubMedSearch in Google Scholar
  • 47 Charon JP, Alaeddin FH, Pimpalwar SA. et al. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol 2004; 15 (11) 1219-1230
    CrossrefPubMedSearch in Google Scholar
  • 48 Tripathi D, Ferguson J, Barkell H. et al. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents. Eur J Gastroenterol Hepatol 2006; 18 (03) 225-232
    CrossrefPubMedSearch in Google Scholar
  • 49 Bureau C, Garcia Pagan JC, Layrargues GP. et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 2007; 27 (06) 742-747
    CrossrefPubMedSearch in Google Scholar
  • 50 Bureau C, Garcia-Pagan JC, Otal P. et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126 (02) 469-475
    CrossrefPubMedSearch in Google Scholar
  • 51 Perarnau JM, Le Gouge A, Nicolas C. et al; STIC-TIPS group. Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. J Hepatol 2014; 60 (05) 962-968
    CrossrefPubMedSearch in Google Scholar
  • 52 Gur I, Diggs BS, Orloff SL. Surgical portosystemic shunts in the era of TIPS and liver transplantation are still relevant. HPB (Oxford) 2014; 16 (05) 481-493
    CrossrefPubMedSearch in Google Scholar
  • 53 Hosokawa I, Adam R, Allard MA. et al. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension. Br J Surg 2017; 104 (04) 443-451
    CrossrefPubMedSearch in Google Scholar
  • 54 Sen I, Yohanathan L, Kärkkäinen JM, Nagorney DM. Current Indications and Long-Term Outcomes of Surgical Portosystemic Shunts in Adults. J Gastrointest Surg 2021; 25 (06) 1437-1444
    CrossrefPubMedSearch in Google Scholar